BMAC – Biopharmaceutical Manufacturer's Advisory Council

Main Menu
Menu
Flyout Menu
Menu
BMAC - Biopharmaceutical Manufacturer's Advisory Council
Quick Links
Main Menu

An initiative by leading Biopharmaceutical companies in the world to establish Singapore as the country of choice for global biomedical sciences manufacturing.

Follow Us:
Linkedin-in

News Year: 2024

BioPIPS consortium in Singapore expands membership, seeks to enhance productivity and sustainability in biologics manufacturing | Singapore EDB

March 18, 2024

The Biologics Pharma Innovation Programme Singapore (BioPIPS) consortium has been expanded with the addition of global immunotherapy company, BioNTech. The company joins global pharmaceutical companies GSK and Sanofi alongside Singapore’s research organisations and institutes of higher learning Agency for Science, Technology and Research (A*STAR), Nanyang Technological University, Singapore (NTU) and its innovation and enterprise company, NTUitive, National University of Singapore (NUS), and Singapore Institute of Technology (SIT).

Read More »

Novartis expands its biopharmaceutical manufacturing site in Singapore

March 15, 2024

Novartis today announced it broke ground for the expansion of its biopharmaceutical manufacturing plant in Singapore. The US$256 million investment will facilitate Novartis in deploying digital and automation solutions to enhance manufacturing productivity, improve operational efficiency, and upskill the workforce. The expanded site will focus on manufacturing therapeutic antibody drugs to deliver breakthrough treatments to patients globally.

Read More »